SpaceX IPO stock settles near issue price as insider lockups loom
Space Exploration Technologies, better known as SpaceX, debuted at an IPO price of $135 and quickly surged after listing before later retracing to trade back around the IPO level in the $150 range. The record-setting offering drew major attention as Elon Musk sold shares to the public as part of the launch, while underwriting boosted the deal size to more than $85 billion.
While the IPO’s spectacle helped fuel the initial run-up, investors are now focused on a more technical factor: insider lockup expirations that could increase the supply of freely tradeable shares over time, adding potential pressure on the stock’s near- to medium-term trading range.
Key takeaways
- Price move: SpaceX shares priced at $135, opened around $150, traded above $200 at the peak, then fell back to roughly the $150 area.
- Catalyst: The IPO initially drove the surge, but insider lockup expirations—with sales permitted through December 2026—create a potential overhang.
- Key implication: As more shares become eligible for sale, increased market supply may contribute to rangebound trading until investors absorb the additional volume.
- Investor takeaway: Short-term traders who bought the momentum may face a different risk/reward than long-term investors focused on the company’s operational outlook.
How the IPO reshaped the stock’s early trading
SpaceX’s IPO was priced at $135 per share. On opening, shares began trading at roughly $150, reflecting strong demand immediately after the offering. The stock then climbed further, reaching just over $200 as enthusiasm around the company intensified.
That momentum did not last. After investors digested the initial hype, the share price declined sharply to $108 before later returning to the mid-$100s, around the $150 range.
Such a pattern is common after major IPOs—especially when expectations are high—but SpaceX’s scale made the early volatility more pronounced.
Why insider lockups could weigh on shares
A central factor for the stock’s trading trajectory is the structure of insider lockups. According to the article, insiders who participated in the IPO—including Elon Musk through share sales to the public—may only be able to monetize gains gradually because insiders are typically restricted from selling immediately after an offering.
In this case, the report said insiders will be able to sell shares on various dates through December 2026. While lockups do not change the total number of shares outstanding, they can affect how many shares are available for trading in the market. As restrictions lift, the number of shares eligible to trade tends to rise, which can increase trading volume and potentially place downward pressure on price if demand does not keep pace.
The article also framed this as a normal dynamic for IPOs, though it noted SpaceX’s deal was not “normal” in scale given its record-setting nature and the high-profile attention it received.
Should investors treat the stock differently now?
The article suggests that strategy depends largely on investment horizon. For long-term investors who view SpaceX as a leading player in space-related industries, the implication is that selling solely because the stock has returned closer to the IPO reference price may not be warranted.
For short-term traders, however, the report points to a different consideration. If investors entered based on IPO momentum—anticipating a rapid, sustained rally—then the lockup-driven increase in supply could become a headwind. The article described insider selling as a potential factor that could keep the stock under pressure at least through late 2026.
In other words, even if the company’s longer-term prospects remain intact, the stock’s medium-term trading could be shaped by supply dynamics tied to unlock schedules.
Bigger picture: IPO mechanics meet high expectations
SpaceX’s IPO demonstrated how quickly investor demand can lift a stock at launch, but also how quickly sentiment can cool once initial trading excitement fades. With shares now nearer the IPO starting point, investors appear to be shifting attention from the offering itself to the market structure around it—specifically the timing of when large holders may increase sales.
The next phase for the stock is likely to be influenced less by IPO-day narratives and more by how the market absorbs additional shares as unlock dates approach, alongside any company-specific developments that could change forward-looking expectations.
What to watch next: Investors will likely focus on upcoming insider sale eligibility through December 2026, along with any company updates that could offset the potential supply overhang. Because the article did not cite additional operational catalysts or new financial guidance, the timing of unlock milestones and the stock’s ability to hold its trading range may be the most immediate items for market participants.
